SOURCE: Stone Point Capital Foundation

November 24, 2009 15:43 ET

Stone Point Capital Foundation Raises Over $500,000 for Rare Liver Cancer Research

GREENWICH, CT--(Marketwire - November 24, 2009) - On October 5th, 2009, the Stone Point Capital Foundation hosted its fifth Charity Golf Tournament and Dinner at The Stanwich Club of Greenwich, to benefit The Fibrolamellar Cancer Foundation. The event drew more than 140 golfers and 200 dinner attendees to hear speakers Dr. Ronald DeMatteo and Dr. David Sidransky discuss fibrolamellar cancer, a rare form of liver cancer that typically occurs in young adults and children. Dr. DeMatteo serves as Vice Chair of the Department of Surgery, Chief of the Division of General Surgical Oncology and Director of the General Surgical Oncology Fellowship Program at Memorial Sloan-Kettering Cancer Center in New York City, and Dr. Sidransky is the Director of Head and Neck Cancer Research in the Department of Otolaryngology - Head and Neck Surgery at Johns Hopkins University. The event raised over $500,000 to support education and research efforts focused on fibrolamellar. Lead sponsors of the event included Stone Point Capital LLC, Debevoise & Plimpton LLP, Amherst Securities Group LP and AXIS Capital Holdings Limited.

"The mission of the Stone Point Capital Foundation and the sponsorship of our most recent charity event reflect our continued commitment to support charitable organizations throughout the tri-state area," said Charles A. Davis, CEO of Stone Point Capital. "We truly appreciate the generosity of our friends and colleagues and look forward to the education and research advances that will be made possible by the Fibrolamellar Cancer Foundation."

Fibrolamellar Cancer Foundation

The Fibrolamellar Cancer Foundation was established by Tucker Davis after he was diagnosed with fibrolamellar hepatocellular carcinoma in August 2008. The Fibrolamellar Cancer Foundation was established to increase awareness and raise research funds for fibrolamellar, a rare form of liver cancer that is primarily diagnosed in teens and young adults. The foundation's mission is to find a cure and reliable treatment options for those diagnosed with this rare disease as well as enhance communication among healthcare professionals and patients. To learn more, please visit or email

Stone Point Capital Foundation

The Stone Point Capital Foundation is a grant making entity dedicated to supporting the needs of charitable organizations primarily in the New York metropolitan area. Past beneficiaries include the Alzheimer's Association, the Children's Aids Society, Memorial Sloan-Kettering Cancer Center, the Michael J. Fox Foundation for Parkinson's Research, the New York Police and Fire Widows' and Children's Benefit Fund and Shake-a-Leg. The Stone Point Capital Foundation, formed in August 2000, is operated by the principals of Stone Point Capital LLC, a global private equity firm based in Greenwich, Connecticut.

Contact Information

  • Contact Information:
    Charles A. Davis
    Stone Point Capital LLC
    (203) 862-2900